Advertisement
Australia markets close in 5 hours 51 minutes
  • ALL ORDS

    7,889.40
    -9.50 (-0.12%)
     
  • ASX 200

    7,632.00
    -10.10 (-0.13%)
     
  • AUD/USD

    0.6413
    -0.0012 (-0.19%)
     
  • OIL

    82.62
    -0.11 (-0.13%)
     
  • GOLD

    2,392.00
    -6.00 (-0.25%)
     
  • Bitcoin AUD

    98,373.06
    +3,179.93 (+3.34%)
     
  • CMC Crypto 200

    1,308.49
    +422.95 (+47.75%)
     
  • AUD/EUR

    0.6027
    -0.0004 (-0.06%)
     
  • AUD/NZD

    1.0875
    0.0000 (0.00%)
     
  • NZX 50

    11,802.54
    -33.50 (-0.28%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,837.40
    +67.38 (+0.38%)
     
  • Hang Seng

    16,385.87
    +134.03 (+0.82%)
     
  • NIKKEI 225

    37,727.78
    -351.92 (-0.92%)
     

Teva buys Allergan generic drug unit for $40.5 bn

Teva will pay $33.75 billion in cash and offer $6.75 billion of its stock to Allergan, the company said, in a major move that will further shake up the industry

Israeli pharmaceutical giant Teva said Monday that it was buying the generic drug business of Allergan for $40.5 billion, consolidating its position as a world leader in generics.

Teva will pay $33.75 billion in cash and offer $6.75 billion of its stock to Allergan, the company said, in a major move that will further shake up the industry.